Vitreous Retina Macula Consultants of New York
VRMNY is a multi-location ophthalmology practice specializing in the diagnosis, medical treatment, and surgery of retinal diseases, serving individual patients across the New York metropolitan area from offices in Manhattan, Brooklyn, and Westchester through a team of internationally recognized retina specialists.
- Company typePrivate
- Founded2006
- HeadquartersNew York, United States
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Vitreous Retina Macula Consultants of New York does
Vitreous Retina Macula Consultants of New York (VRMNY) is a privately-held ophthalmology practice specializing in the diagnosis, medical management, and surgical treatment of retinal diseases. Founded by Dr. Lawrence A. Yannuzzi and operating from four locations across the New York metropolitan area (Midtown Manhattan, Downtown Manhattan, Brooklyn, and Westchester County), the practice positions itself as the largest retina vitreous center in the region. Its clinical scope covers age-related macular degeneration, diabetic retinopathy, retinal tears and detachments, macular holes, vitreomacular traction, floaters, central serous chorioretinopathy, and related vitreo-retinal conditions, delivered through diagnostic imaging services (OCT, OCTA, fluorescein and ICG angiography, ultra-widefield imaging, swept-source OCT, adaptive optics, microperimetry, Humphrey visual field), in-office procedures (intravitreal injections of agents such as Avastin, Eylea, Lucentis, Ozurdex, Iluvien, Jetrea; laser surgeries including panretinal photocoagulation and photodynamic therapy), and operating-room surgical procedures (trans pars plana vitrectomy, scleral buckle, membrane peel, retinal detachment repair, floater-only vitrectomy).
The practice generates revenue primarily through professional services billed to Medicare, Medicaid, and commercial carriers (EmblemHealth, UnitedHealthcare, Aetna, Empire Blue Cross Blue Shield), supplemented by patient co-pays and self-pay revenue. A second revenue stream is clinical-trial site participation; VRMNY has enrolled patients in the MAKO Phase III trial (squalamine eye drops for wet AMD, sponsored by Ohr Pharmaceutical) and the BOULEVARD Phase II trial (anti-VEGF plus anti-Ang2 combination therapy for diabetic macular edema). Additional revenue and reputational assets derive from a fellowship training program operated jointly with Columbia University and Northwell/Manhattan Eye, Ear & Throat Hospital, drawing up to five international retinal specialists to the practice at any time. Patient acquisition is sales-led through physician referrals, insurance networks, direct website/phone booking, Zocdoc, and physician-to-physician academic visibility via the practice's unusually high peer-reviewed publication output (the practice's physicians collectively publish more in foremost U.S. journals than any other private or academic group in the country, with founder Dr. Yannuzzi alone credited with 400+ papers and 13 books).
Vitreous Retina Macula Consultants of New York firmographics
Firmographics- Name
- Vitreous Retina Macula Consultants of New York
- Legal name
- Vitreous Retina Macula Consultants of New York
- Website
- https://vrmny.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- VRMNY is a multi-location ophthalmology practice specializing in the diagnosis, medical treatment, and surgery of retinal diseases, serving individual patients across the New York metropolitan area from offices in Manhattan, Brooklyn, and Westchester through a team of internationally recognized retina specialists.
- Ownership category
- akta.pro rank
Vitreous Retina Macula Consultants of New York industry classification
Industry- Product category
- Retinal Ophthalmology Services
- NAICS
- Offices of Physicians (except Mental Health Specialists) (621111)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Retina & Vitreous Specialists (HLAKAKAE)
- akta.pro secondary industries
- Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN), Ambulatory Surgery Centers (Ophthalmic/Outpatient Eye Surgery) (HLAKAKAO)
Keywords
Where Vitreous Retina Macula Consultants of New York is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Vitreous Retina Macula Consultants of New York business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
Revenue model
- Medical and Surgical Retina Services: VRMNY generates revenue through professional medical services including comprehensive ophthalmology examinations, diagnostic testing, medical treatments for retinal conditions, and surgical procedures. Revenue is collected through insurance reimbursements from Medicare, Medicaid, and commercial insurance plans, as well as patient co-pays and self-pay for non-covered services.
- Clinical Trial Participation: The practice conducts clinical trials (MAKO, BOULEVARD) where patients receive compensated study treatments, providing research funding and drug company partnerships.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Vitreous Retina Macula Consultants of New York product offering
Product offeringCore offering
VRMNY is a multi-location ophthalmology practice specializing in the diagnosis and treatment of medical and surgical retinal conditions. Its offering spans comprehensive diagnostic imaging (OCTA, fluorescein/ICG angiography, ultra-widefield imaging, swept-source OCT, adaptive optics), in-office procedures (intravitreal injections and laser surgeries), surgical interventions (vitrectomy, scleral buckle, retinal detachment repair), medication-based therapies (Avastin, Eylea, Lucentis, and others), and sponsored clinical trials. The practice operates from four offices in the New York Metropolitan area, serving both self-referred patients and physician referrals.
Product overview
VRMNY operates as a multi-location ophthalmology and retina specialty practice offering a comprehensive range of eye care services. The core offering consists of diagnostic imaging services (including OCTA, fluorescein angiography, ultra-widefield imaging), in-office procedures (intravitreal injections, various laser surgeries), and surgical procedures (vitrectomy, retinal detachment repair, scleral buckle). The practice also provides medical treatments with various injectable medications and runs clinical trials (MAKO, BOULEVARD) for cutting-edge therapies. Additionally, VRMNY offers fellowship training programs for physicians in conjunction with Columbia University and Northwell/Manhattan Eye, Ear & Throat Hospital. Services are delivered across four locations in Manhattan, Brooklyn, and Westchester.
Differentiator
Problem solved
Functional benefit
Products and services
- Diagnostic Imaging Services Comprehensive diagnostic imaging services for retinal disease evaluation, including Optical Coherence Tomography Angiography (OCTA), fluorescein angiography, indocyanine green angiography, fundus photography, adaptive optics, swept source OCT, ultra-widefield imaging, microperimetry, and Humphrey Visual Field testing. Provided to patients referred for retinal evaluation and to referring physicians.
- In-Office Procedures Minimally invasive procedures performed at VRMNY offices, including intravitreal injections and laser surgeries such as panretinal photocoagulation, photodynamic therapy, YAG capsulotomy, focal laser, prophylactic laser, indirect laser, and cryotherapy. Delivered to patients with retinal conditions across all four office locations.
- Surgical Procedures Advanced retinal surgical procedures including trans pars plana vitrectomy (TPPV), scleral buckle, membrane peel, retinal detachment repair, floater-only vitrectomy, and lensectomy. Provided to patients requiring surgical intervention for retinal disease.
- Medical Treatments Medication-based retinal treatments using Avastin, Eylea, Lucentis, Triamcinolone, Triesence, Visudyne, Ozurdex, Iluvien, and Jetrea to treat various retinal conditions including age-related macular degeneration, diabetic retinopathy, and macular edema. Delivered to patients under physician supervision across all four locations.
- Fellowship Training Program Medical-surgical retina fellowship (2-year program) and medical retina fellowship (1-year program) for international and domestic retinal physicians seeking subspecialty training, conducted in conjunction with Columbia University and Northwell/Manhattan Eye, Ear & Throat Hospital. Up to 5 international retinal specialists conduct research at VRMNY at any time.
- MAKO Clinical Trial Phase III clinical trial for newly diagnosed wet age-related macular degeneration testing squalamine eye drops as an adjunct to standard anti-VEGF therapy, sponsored by Ohr Pharmaceutical Inc. Patients receive compensated study treatments at VRMNY.
- BOULEVARD Clinical Trial Phase II clinical trial for newly diagnosed diabetic macular edema testing a combination drug targeting both anti-VEGF and anti-Ang2 pathways versus standard Lucentis injections. Patients are recruited and treated at VRMNY.
Quantifiable outcome
- 4.9 star rating from 1,900+ patient reviews
- +1 more outcomes
Companies that use Vitreous Retina Macula Consultants of New York
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Vitreous Retina Macula Consultants of New York technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Vitreous Retina Macula Consultants of New York partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor and core.
- American Diabetes Association - Greater New YorkminorVRMNY partners with American Diabetes Association-Greater New York for the annual Diabetes & Education Night event featuring education lectures, free eye screenings, and refreshments to educate patients about diabetes and its effects on eye health.
- Ohr Pharmaceutical InccoreOhr Pharmaceutical is the sponsor of the MAKO clinical trial conducted at VRMNY. This Phase III study tests squalamine eye drops as a potential wet macular degeneration treatment in combination with standard anti-VEGF therapy.
- Clinical Trials (BOULEVARD Study)coreBOULEVARD study is a Phase II clinical trial for diabetic macular edema testing a new combination drug (anti-VEGF + anti-Ang2) versus standard Lucentis injections. VRMNY recruits and treats patients for this study.
Scale indicators7 records
Recent moves9 records
Expansion highlights5 records
Vitreous Retina Macula Consultants of New York competitors and assessment
Company assessmentBroad incumbents
- Bascom Palmer Eye Institute: A top-ranked U.S. academic eye institute with one of the most active retinal research and clinical trial programs in the country — comparable to VRMNY in retinal subspecialty focus, publications output, and clinical trial participation, but in an academic setting.
- Wills Eye Hospital: A nationally ranked specialty ophthalmology hospital in Philadelphia with a renowned retina service and fellowship training — analogous to a scaled-up, academic counterpart to VRMNY's retina-specialist model.
- Retina Consultants of America: A PE-backed platform aggregating leading retina practices across the U.S.; represents the strategic counterparty/aggregator in the same retina-specialty space, directly comparable to a multi-office VRMNY in service lines while operating at significantly larger scale.
- New York Eye and Ear Infirmary of Mount Sinai: A premier academic ophthalmology institution with which VRMNY physicians hold academic appointments and through which Dr. Yannuzzi directs the LuEsther T. Mertz Retinal Research Center — overlapping in retinal subspecialty care, research, and clinical training.
Direct peers
- Retina Associates of Sarasota: A long-standing private retina subspecialty group offering medical retina, vitreoretinal surgery, and clinical research — structurally analogous to VRMNY as an independent multi-physician retina practice.
- Retina Group of Washington: A large, multi-physician retina subspecialty practice in the Washington DC/Mid-Atlantic region with a comparable mix of medical retina, vitreoretinal surgery, and clinical research — directly analogous in scale and service mix to VRMNY.
- Mid Atlantic Retina: One of the largest retina specialty practices on the U.S. East Coast with multiple offices and a heavy focus on vitreoretinal surgery and AMD/DME care — a near-direct analog to VRMNY's positioning, serving the Mid-Atlantic as VRMNY serves the New York metro.
- California Retina Consultants: A leading West Coast multi-location retina subspecialty group with deep involvement in clinical trials for AMD and DME — comparable in its combination of large private retina practice operations and sponsored research activity to VRMNY.
Regional players
- Ophthalmic Consultants of Long Island: A multi-subspecialty ophthalmology group in the New York metro region offering retina care alongside cataract and comprehensive services — comparable as a competing regional eye-care provider in the same NYC-area footprint.
- Palmetto Retina Center: A private retina specialty practice in the Southeast U.S. focused on medical and surgical retinal disease — directly comparable in offering and patient mix to VRMNY, though operating in a different regional market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Vitreous Retina Macula Consultants of New York social profiles
Digital presenceVitreous Retina Macula Consultants of New York financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vitreous Retina Macula Consultants of New York leadership team
Management profileNumber of profiles
Profiles13 records
Vitreous Retina Macula Consultants of New York funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vitreous Retina Macula Consultants of New York M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vitreous Retina Macula Consultants of New York
What does Vitreous Retina Macula Consultants of New York do?
VRMNY is a multi-location ophthalmology practice specializing in the diagnosis and treatment of medical and surgical retinal conditions. Its offering spans comprehensive diagnostic imaging (OCTA, fluorescein/ICG angiography, ultra-widefield imaging, swept-source OCT, adaptive optics), in-office procedures (intravitreal injections and laser surgeries), surgical interventions (vitrectomy, scleral buckle, retinal detachment repair), medication-based therapies (Avastin, Eylea, Lucentis, and others), and sponsored clinical trials. The practice operates from four offices in the New York Metropolitan area, serving both self-referred patients and physician referrals.
Is Vitreous Retina Macula Consultants of New York a public or private company?
Vitreous Retina Macula Consultants of New York is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Vitreous Retina Macula Consultants of New York founded?
Vitreous Retina Macula Consultants of New York was founded in 2006. It employs 51 to 100 people.
Where is Vitreous Retina Macula Consultants of New York based?
Vitreous Retina Macula Consultants of New York is headquartered in New York, United States, in the North America region.
How does Vitreous Retina Macula Consultants of New York make money?
Two revenue lines are on record. Medical and Surgical Retina Services are the primary driver. The others are clinical Trial Participation.
Who are Vitreous Retina Macula Consultants of New York's main competitors?
Broad incumbents on record are Bascom Palmer Eye Institute, Wills Eye Hospital, Retina Consultants of America and New York Eye and Ear Infirmary of Mount Sinai. Direct peers are Retina Associates of Sarasota, Retina Group of Washington, Mid Atlantic Retina and California Retina Consultants. Regional players are Ophthalmic Consultants of Long Island and Palmetto Retina Center.
Does Vitreous Retina Macula Consultants of New York have an API?
No public API is recorded for Vitreous Retina Macula Consultants of New York.
What industry is Vitreous Retina Macula Consultants of New York in?
Vitreous Retina Macula Consultants of New York's product category is Retinal Ophthalmology Services. Its primary akta.pro industry code is HLAKAKAE, Retina & Vitreous Specialists, with a secondary code of HLAKAKAN, Ocular Imaging & Diagnostic Testing Centers. Its NAICS code is 621111 and its SIC code is 8011.